522 results on '"Wu, Shang-Ju"'
Search Results
2. Multicolour and lineage-specific interphase chromosome Flow-FISH: method development and clinical validation
3. Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan
4. Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies
5. Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies
6. Immunotherapeutic potential of blinatumomab-secreting γ9δ2 T Cells
7. Levosimendan attenuates electrical alternans and prevents ventricular arrhythmia during therapeutic hypothermia in isolated rabbit hearts
8. Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesis
9. Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients
10. Application of Sample Entropy to Analyze Consciousness in CLIS Patients
11. Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
12. Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
13. Pevonedistat in East Asian patients with acute myeloid leukemia or myelodysplastic syndromes: a phase 1/1b study to evaluate safety, pharmacokinetics and activity as a single agent and in combination with azacitidine
14. Sudden cardiac death in heart failure with preserved ejection fraction: an updated review
15. Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations
16. Serum Methotrexate Level Predicts Acute Kidney Injury After High-Dose Methotrexate: A Case Report and Single-Center Experience.
17. Updated quality of life data from the phase 3b VENICE II trial: patients with relapsed or refractory chronic lymphocytic leukemia receiving venetoclax monotherapy.
18. Glofitamab monotherapy retreatment in patients with heavily pre-treated relapsed or refractory (R/R) non-Hodgkin lymphoma (NHL): Results from a phase I/II study.
19. Signal-averaged electrocardiography as a noninvasive tool for evaluating the ventricular substrate in patients with nonischemic cardiomyopathy: reassessment of an old tool
20. Coexistent diffuse large B-cell lymphoma and disseminated Mycobacterium avium complex infection in a person with AIDS
21. Glofitamab as a salvage treatment for B‐cell lymphomas in the real world: A multicenter study in Taiwan
22. Catheter ablation in patients with atrial fibrillation and dilated cardiomyopathy
23. Application of Sample Entropy to Analyze Consciousness in CLIS Patients
24. Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
25. Successful treatment of nasal-type extra-nodal natural killer/T cell lymphoma with simultaneous involvement of the thyroid, liver, and pancreas
26. Improved outcomes of localized diffuse large B‐cell lymphoma at the Waldeyer ring in comparison to the sinonasal area in the rituximab era
27. Comparison of Long-Term Clinical Outcomes Between Segmental and Circumferential Pulmonary Vein Isolation in Patients Undergoing Repeat Atrial Fibrillation Ablation
28. Clinical significance of substrate characteristics and ablation outcomes in patients with atrial fibrillation and significant functional mitral regurgitation
29. POSTER: ABCL-478 Glofitamab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies: Results From a Pivotal Phase II Expansion Study
30. ABCL-478 Glofitamab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies: Results From a Pivotal Phase II Expansion Study
31. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
32. PO-02-159 ABLATION OF ATRIAL FIBRILLATION AND DEMENTIA RISK REDUCTION DURING LONG-TERM FOLLOW-UP: A NATIONWIDE POPULATION-BASED STUDY
33. PO-02-101 CATHETER ABLATION IN ASIAN PATIENTS WITH ATRIAL FIBRILLATION AND DILATED CARDIOMYOPATHY: ELECTROPHYSIOLOGICAL CHARACTERISTICS OF RECURRENCE AND LONG-TERM CLINICAL OUTCOMES
34. PO-04-169 DELAYED EFFECT OF CATHETER ABLATION FOR INTRAMURAL OUTFLOW TRACT VENTRICULAR ARRHYTHMIAS
35. PO-02-199 A NOVEL FINDING: SERUM MICRORNA-122 CORRELATES WITH LEFT ATRIAL SUBSTRATE IN PATIENTS WITH ATRIAL FIBRILLATION
36. PO-05-073 CHARACTERISTICS OF BIPOLAR AND UNIPOLAR ELECTROGRAMS AT SUCCESSFUL ABLATION TARGETS FOR VENTRICULAR ARRHYTHMIA ORIGINATING FROM THE VICINITY OF LEFT VENTRICULAR SUMMIT
37. PO-01-228 CLINICAL SIGNIFICANCE OF STRUCTURAL REMODELING CONCERNING SUBSTRATE CHARACTERISTICS AND ABLATION OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION AND MITRAL REGURGITATION
38. PO-05-021 HYPERTROPHIC CARDIOMYOPATHY INCREASES THE RISKS OF BRADYARRHYTHMIA AND PACEMAKER IMPLANTATION
39. Data from Phosphoproteomics Reveals the Role of Constitutive KAP1 Phosphorylation by B-cell Receptor Signaling in Chronic Lymphocytic Leukemia
40. Supplementary Data from Phosphoproteomics Reveals the Role of Constitutive KAP1 Phosphorylation by B-cell Receptor Signaling in Chronic Lymphocytic Leukemia
41. Supplementary Table 1 from Nucleophosmin Mutations in De novo Acute Myeloid Leukemia: The Age-Dependent Incidences and the Stability during Disease Evolution
42. Coexistent disseminated Kaposi's sarcoma and disseminated Mycobacterium avium complex infection in a patient with AIDS
43. Concerted mass spectrometry-based glycomic approach for precision mapping of sulfo sialylated N-glycans on human peripheral blood mononuclear cells and lymphocytes
44. Inotuzumab ozogamicin as a single agent to treat T315I-mutated chronic myeloid leukemia with acute blastic change to CD22+ acute lymphocytic leukemia
45. GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
46. Design and Evaluation of a Real Time Physiological Signals Acquisition System Implemented in Multi-Operating Rooms for Anesthesia
47. Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome
48. Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
49. Cerebrospinal fluid soluble programmed death‐ligand 1 is a useful prognostic biomarker in primary central nervous system lymphoma
50. Inotuzumab ozogamicin as a single agent to treat T315I-mutated chronic myeloid leukemia with acute blastic change to CD22+ acute lymphocytic leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.